Datasea Announces Breakthrough in Acoustic-Driven Brain-Computer Interface Technology

Rhea-AI Summary

Datasea (NASDAQ: DTSS) announced engineering-stage completion of two acoustic-driven brain–computer interface technologies on December 11, 2025: a Real-Time Closed-Loop Vibration-Enhanced BCI System and an Acoustic-Coupled EEG Signal Enhancement System. The systems provide an integrated framework for brain-signal acquisition, decoding, feedback modulation, missing-signal reconstruction, and acoustic-field enhancement.

The company says these technologies aim to improve EEG SNR, dynamic decoding of signals (eg, motor intention), and closed-loop responsiveness, with potential future applications in healthcare, neuromodulation, rehabilitation, consumer wellness devices, and human–machine interaction, subject to further development, validation, and regulatory review.

Key Figures

Global BCI market USD 15–20 billion Projected market size by 2030 per Grand View Research (2024)

Market Reality Check

$1.23 Last Close

Volume Volume 7,228 is well below 20-day average 61,440 (relative volume 0.12). low

Technical Shares last closed at 1.23, trading below the 200-day MA of 1.99 and 60.32% under the 52-week high.

Peers on Argus

DTSS gained 2.5% while key software peers like BLIN, BNAI, FAAS, OLB, and MSAI showed declines between -1.1% and -8.3%, indicating stock-specific strength rather than a sector-wide move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 18	Trading update	Positive	+14.5%	Addressed unusual trading, highlighted solid Q1 gross profit and BCI progress.
Nov 13	Quarterly earnings	Neutral	-4.0%	Revenue fell as mix shifted, but gross profit and margin improved substantially.
Sep 26	Annual results	Positive	-10.2%	Reported strong FY2025 revenue and gross profit growth with segment expansion.
Sep 11	Commercial contract	Positive	-5.3%	Signed 12‑month acoustic smart health shoes agreement with minimum fee and upside.
Aug 18	Tech breakthrough	Positive	+4.1%	Announced acoustic neuromodulation breakthrough targeting large healthcare markets.

Pattern Detected

News flow has often been positive, but price reactions are mixed: some technology and commercialization updates aligned with gains, while strong revenue and contract headlines previously saw negative reactions, indicating inconsistent follow-through on good news.

Recent Company History

Over the last few months, Datasea reported rapid growth, with FY2025 revenue reaching $71.62 million and gross profit up sharply, yet those strong results on Sep 26 were followed by a -10.17% move. A landmark acoustic wearable contract on Sep 11 also saw a negative reaction. More recently, Q1 FY2026 earnings on Nov 13 showed revenue decline but much higher margins and a modest share pullback. A Nov 18 update on trading activity and acoustic/BCI progress coincided with a 14.53% gain, providing context for today’s new BCI technology milestone.

Market Pulse Summary

This announcement details completion of engineering-stage development for Datasea’s acoustic-driven BCI systems, enabling brain-signal acquisition, decoding, feedback modulation, and acoustic-field enhancement. It extends prior work in acoustic neuromodulation toward non-invasive healthcare and intelligent interaction applications. In context of earlier breakthroughs and commercialization efforts, key watchpoints include validation data, regulatory pathways, and tangible contracts that link this BCI platform to revenue within Datasea’s broader acoustics and AI strategy.

Key Terms

eeg medical

"Acoustic-Coupled EEG Signal Enhancement System have successfully completed"

An EEG (electroencephalogram) is a medical test that records the brain’s electrical activity through small sensors placed on the scalp, similar to reading patterns of a city’s traffic to understand flow and disruptions. For investors, EEGs matter because they are central to diagnosing and monitoring neurological conditions, validating new brain-related treatments or devices, and supporting regulatory approvals and reimbursement — factors that drive market demand and revenue potential. Changes in EEG technology, usage or guidelines can affect companies that make the equipment, offer related services, or develop therapies tied to brain signals.

neuromodulation medical

"applications in areas such as healthcare, neuromodulation, and intelligent interaction"

Neuromodulation is the use of devices or targeted treatments to change how nerves or brain circuits send signals, much like adjusting the volume or tuning on an audio system to alter what you hear. For investors, it matters because these therapies can treat chronic conditions (pain, movement disorders, depression) where existing medicines fall short, creating potential markets, regulatory milestones, and durable revenue streams if technologies prove safe and effective.

AI-generated analysis. Not financial advice.

Developing Healthcare and Intelligent Interaction Through Core Acoustic Innovation

BEIJING, Dec. 11, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology enterprise specializing in acoustic high-tech innovations and AI multimodal digital solutions, today announced progress in its research and development efforts related to brain–computer interfaces (BCI) technologies. The Company's Real-Time Closed-Loop Vibration-Enhanced BCI System and Acoustic-Coupled EEG Signal Enhancement System have successfully completed engineering-stage development. These technologies enable an integrated technical framework supporting brain-signal acquisition, decoding, feedback modulation, missing-signal reconstruction, and acoustic-field enhancement.

The Company believes this development provides a technical basis for potential future applications in areas such as healthcare, neuromodulation, and intelligent interaction, subject to further development, validation, and regulatory review.

Core Technological Highlights: Application of Acoustic Technology in Non-Invasive BCI

Through the application of its acoustic technologies in the BCI field, Datasea focuses on improving the unstable signal quality and insufficient decoding accuracy.

1. Establishing New Capabilities in Dynamic Decoding and Closed-Loop Optimization

Traditional BCIs rely on static algorithms that struggle to adapt to rapid fluctuations in EEG signals. Datasea's real-time closed-loop vibration enhancement approach is designed to support dynamic decoding and feedback-based optimization, with potential benefits including:

• Improved interpretation of key brain signals, such as motor intention;
• Enhanced performance in complex or noisy environments;
• Automatic algorithm adjustment for improved real-time responsiveness.

2. Acoustic-Coupled EEG Signal Enhancement

EEG signals are highly susceptible to interference during acquisition.

Datasea's acoustic-coupled enhancement technology is intended to:

• Assisst in detecting and reconstructing missing or weakened EEG segments more effectively;
• improve signal-to-noise ratio (SNR) and data completeness;
• Support more consistent performance in operation in real-world application scenarios.

Potential Application Areas

With system-level integration completed at the engineering stage, Datasea expects that its technologies may support further development toward practical applications, including:

• Improved rehabilitation outcomes for motor recovery and neuromodulation;
• Non-invasive consumer and wellness devices;
• Human–machine interaction for intelligent devices and accessibility tools;
• Broader integration within the Company's acoustics and AI technology portfolio.

Datasea plans to accelerate commercialization across multiple industries, subject to continued technical verification, regulatory considerations and market conditions.

Market Context

According to industry research reports published by Grand View Research (2024) :

• The global BCI market is projected to exceed USD 15–20 billion by 2030;
• Non-invasive BCI is expected to be a fast-growing segment due to its safety, accessibility, and broader application potential;
• Healthcare rehabilitation, consumer electronics, and intelligent wearables are anticipated to be the key demand drivers over the next decade.

The Company believes these trends support continued long-term research interest in BCI-related technologies.

CEO Statement

Ms. Zhixin Liu, Chief Executive Officer of Datasea, commented:

"We believe this progress in Datasea's acoustic technologies for brain–computer interfaces marks the successful completion of our core EEG technology chain and establishes a distinctive and robust competitive advantage through sound-wave coupling and closed-loop vibration enhancement.

We believe Datasea's technologies—including our BCI innovations—hold significant commercialization potential and strong industry value across healthcare, intelligent interaction, and the broader future of human–machine integration.

Under our strategic framework of 'Acoustic Technology + Multi-Scenario Applications,' we believe the Company will continue to advance innovation and accelerate the deployment of acoustics-driven solutions across a wide range of industries.

Going forward, we remain committed to driving technology transfer, expanding partnerships, and opening new application scenarios, thereby creating sustainable and high-quality long-term growth for our shareholders."

About Datasea Inc.

Datasea Inc. ("Datasea") is a leading provider of products, services, and solutions for enterprise and retail customers in two innovative industries, acoustic high tech and 5G-AI multimodal digitalization. The Company's advanced R&D technology serves as the core infrastructure and backbone for its products. Its 5G multimodal digital segment operates on a cloud platform based on AI. Datasea leverages cutting-edge technologies, precision manufacturing, and ultrasonic, infrasound and directional sound technology in its acoustics business to combat viruses and prevent human infections, and it is also developing applications in medical ultrasonic cosmetology. In July 2023, Datasea established a wholly-owned subsidiary, Datasea Acoustics LLC, in Delaware, in a strategic move to enter the U.S. markets and to mark its global expansion plan. For additional information, please visit www.dataseainc.com.

Cautionary Note Regarding Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook," "objective" and similar terms. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond Datasea's control, which may cause Datasea's actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to Datasea as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in Datasea's filings with the SEC, which are available at www.sec.gov. Datasea does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Investor and Media Contact: 

Datasea Investor Relations
Email:  investorrelations@shuhaixinxi.com
                        sunhezhi@shuhaixinxi.com

Precept Investor Relations LLC
David Rudnick
+1 646-694-8538
david.rudnick@preceptir.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/datasea-announces-breakthrough-in-acoustic-driven-braincomputer-interface-technology-302638934.html

SOURCE Datasea Inc.

FAQ

What did Datasea (DTSS) announce on December 11, 2025 about BCI technology?

Datasea announced engineering-stage completion of a Real-Time Closed-Loop Vibration-Enhanced BCI and an Acoustic-Coupled EEG Signal Enhancement system.

How could Datasea's acoustic BCI tech affect rehabilitation and neuromodulation for DTSS shareholders?

The company says the technologies aim to improve EEG signal quality and dynamic decoding, which may support future rehabilitation and neuromodulation applications if validated and approved.

What are the main technical claims of Datasea's DTSS acoustic BCI systems?

Claims include improved EEG signal-to-noise ratio, missing-signal reconstruction, dynamic decoding of motor intentions, and closed-loop feedback optimization.

Does Datasea (DTSS) report commercial or regulatory approvals for the new BCI systems?

No; Datasea states the systems are at engineering-stage development and commercialization depends on further verification and regulatory review.

What timelines or next steps did Datasea provide for DTSS commercialization of its BCI technologies?

Datasea said it plans to accelerate commercialization across industries but provided no specific timelines, noting further technical verification, regulatory considerations, and market conditions are required.